High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Abstract The purpose of this retrospective study was to compare the efficacy and toxicity of high‐dose methotrexate plus temozolomide (MT regimen) and rituximab plus MT (RMT regimen) in patients with untreated primary central nervous system lymphoma (PCNSL). A total of 62 patients with untreated PCN...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Cui Chen, Peng Sun, Juan Cui, Shumei Yan, Hao Chen, Yi Xia, Xiwen Bi, Panpan Liu, Yu Wang, Hang Yang, Man Nie, Xue‐Wen Zhang, Wenqi Jiang, Zhi‐Ming Li
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2019-04-01
Serie:	Cancer Medicine
Soggetti:	chemotherapy high‐dose methotrexate (HD‐MTX) primary central nervous system lymphoma (PCNSL) rituximab temozolomide (TMZ)
Accesso online:	https://doi.org/10.1002/cam4.1906
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!